Julia York is a partner with Skadden in Washington, D.C. She has represented numerous global corporations in various industries, including pharmaceuticals, telecommunications, energy and financial markets, in both litigation and transactional matters. Selected experience includes: defending Sprint Corp. in a lawsuit brought by state attorneys general challenging the proposed acquisition of Sprint by T-Mobile; defending Norfolk Southern Railway Company in multidistrict litigation alleging a conspiracy to fix fuel surcharges; defending Glencore affiliate Access World (USA) LLC in litigation alleging conspiratorial conduct in the primary aluminum industry; defending Sabre Corp. in a merger challenge brought by the U.S. Department of Justice and in antitrust litigation brought by US Airways; defending Actavis, Inc. in a suit brought by the Federal Trade Commission (FTC), including before the Supreme Court of the United States, challenging the legality of a patent litigation settlement; defending Actavis, Inc. and Teva Pharmaceuticals U.S., Inc. in “reverse-payment” litigation related to the brand-name drug AndroGel 1%; defending Medicis Pharmaceutical Corp. in multidistrict “reverse-payment” class action litigation related to the acne product Solodyn; representing Johnson-Matthey in a suit brought by Actelion Pharmaceuticals Ltd. against multiple prospective generic manufacturers involving monopolization and restraint of trade claims in connection with Actelion’s REMS and restricted pharmaceutical distribution programs; representing brand-name and generic pharmaceutical companies in connection with FTC investigations and inquiries; defending a pharmaceutical company CEO in a challenge to an FTC investigation; defending Energy Transfer Partners in an antitrust class action alleging conspiracy and predatory pricing in the Texas natural gas market; and representing a financial futures exchange during a U.S. Department of Justice (DOJ) investigation into a proposed joint venture. Ms. York also counsels clients on various antitrust matters and has participated on panels discussing antitrust issues relevant to the pharmaceutical industry. Ms. York actively works on pro bono matters, including representing various amici curiae on briefs submitted to the U.S. Supreme Court and various U.S. Circuit Courts of Appeal. She has been named in The Legal 500 U.S. Prior to joining Skadden, Ms. York counseled clients from diverse industries in connection with DOJ and FTC investigations into mergers and acquisitions. Other prior experience includes representing a television industry client in a DOJ criminal price-fixing investigation, as well as representing a telecommunications industry client and an aluminum industry client in international arbitration proceedings in Switzerland.

2022 Awards


Nominee, 2022 Antitrust Writing Awards: Academic, Mergers

Send a message